Sancuso + IV granisetron
Phase 1Withdrawn 0 watching 0 views this weekπ€ Quiet
33
Development Stage
β
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Chemotherapy Induced Nausea and Vomiting
Conditions
Chemotherapy Induced Nausea and Vomiting
Trial Timeline
β β β
NCT ID
NCT01596426About Sancuso + IV granisetron
Sancuso + IV granisetron is a phase 1 stage product being developed by Kyowa Kirin for Chemotherapy Induced Nausea and Vomiting. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT01596426. Target conditions include Chemotherapy Induced Nausea and Vomiting.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01596426 | Phase 1 | Withdrawn |
| NCT01596413 | Phase 1 | Withdrawn |
Competing Products
20 competing products in Chemotherapy Induced Nausea and Vomiting